HAEMONETICS CORP — Director's Dealing 2014

Aug 14, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2014-08-12

Reporting Person: MERRIMAN RONALD (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-08-12	Common Stock	S	2274.0	$35.893	Disposed	12105	Direct
2014-08-12	Common Stock	M	11328.0	$29.23	Acquired	23433	Direct
2014-08-12	Common Stock	S	11328.0	$35.7318	Disposed	12105	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-08-12	Non-Qualified Stock Option (right to buy)	$29.23	M	11328.0	Disposed	2015-07-31	Common Stock (11328)	Direct

Footnotes

F1: Grant to reporting person of right to buy shares of common stock exercisable 100 percent on the first anniversary of the date of grant.